Literature DB >> 28708509

GDF8 activates p38 MAPK signaling during porcine oocyte maturation in vitro.

Junchul David Yoon1, Seon-Ung Hwang1, Eunhye Kim1, Minghui Jin1, Soochong Kim2, Sang-Hwan Hyun3.   

Abstract

Growth Differentiation Factor 8 (GDF8) is a member of the transforming growth factor-β (TGF-β) family and has been identified as a strong physiological regulator. This factor is expressed as a paracrine factor in mural granulosa cells. To investigate the effects of GDF8 on the in vitro maturation (IVM) of porcine oocytes, we assessed the quality of matured oocytes as well as the specific gene transcription and protein activation levels in oocytes and cumulus cells (CCs) after IVM and subsequent embryonic development after in vitro fertilization (IVF) and parthenogenetic activation (PA). Supplemental concentrations (0, 1, 10, and 100 ng/ml) of GDF8 were provided in IVM medium. Supplementation with GDF8 during IVM induced transcription of specific TGF-β receptor genes, such as ActRIIb and Alk4/5, and the recognition of the GDF8 by these receptors induced phosphorylation of p38 MAPK. Activated p38 MAPK signaling changed oocyte maturation and cumulus expansion-related gene transcription: Nrf2 and Bcl-2 in oocytes and PCNA, Nrf2, Has2, Ptx3, and TNFAIP6 in CCs. The altered gene expression pattern during IVM resulted in a 10% lower level of intracellular ROS in mature oocytes. The improved cytoplasmic maturation led to an increase in the fertilization efficiency and subsequent embryonic developmental competence. The embryonic development showed increases in the blastocyst formation rate and higher transcription levels of POU5F1 and BCL-2 in the blastocysts. The present study suggests that supplementation of GDF8 during IVM synergistically improved the developmental potential of IVF- and PA-derived porcine embryos by reducing the intracellular ROS level in oocytes by altering the transcription of specific genes and increasing the phosphorylation of p38 MAPK during IVM. In conclusion, for the first time, our results demonstrate that GDF8 can act as a paracrine factor to modulate oocyte maturation by regulating p38 MAPK phosphorylation and intracellular ROS level during porcine IVM.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  GDF8; In vitro maturation; Oocyte; Porcine; p38 MAPK

Mesh:

Substances:

Year:  2017        PMID: 28708509     DOI: 10.1016/j.theriogenology.2017.06.003

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  5 in total

1.  Stimulatory effects of TGFα in granulosa cells of bovine small antral follicles.

Authors:  Allie L Lundberg; Nicole M Jaskiewicz; Abigail M Maucieri; David H Townson
Journal:  J Anim Sci       Date:  2022-07-01       Impact factor: 3.338

2.  Hydroxyurea affects in vitro porcine oocyte maturation through increased apoptosis and oxidative stress.

Authors:  Wei Gao; Yongxun Jin; Jindong Hao; Siyi Huang; Dongxu Wang; Fushi Quan; Mingjun Zhang; Jiabao Zhang; Wenzhi Ren; Xianfeng Yu
Journal:  Biosci Rep       Date:  2021-04-30       Impact factor: 3.840

3.  Physiological and Functional Roles of Neurotrophin-4 During In Vitro Maturation of Porcine Cumulus-Oocyte Complexes.

Authors:  Mirae Kim; Seon-Ung Hwang; Junchul David Yoon; Joohyeong Lee; Eunhye Kim; Lian Cai; Hyerin Choi; Dongjin Oh; Gabsang Lee; Sang-Hwan Hyun
Journal:  Front Cell Dev Biol       Date:  2022-07-08

4.  Procyanidin B1 promotes in vitro maturation of pig oocytes by reducing oxidative stress.

Authors:  Wei Gao; Yongxun Jin; Jindong Hao; Siyi Huang; Dongxu Wang; Fushi Quan; Wenzhi Ren; Jiabao Zhang; Mingjun Zhang; Xianfeng Yu
Journal:  Mol Reprod Dev       Date:  2020-11-25       Impact factor: 2.609

5.  Effect of Interleukin-7 on In Vitro Maturation of Porcine Cumulus-Oocyte Complexes and Subsequent Developmental Potential after Parthenogenetic Activation.

Authors:  Dongjin Oh; Joohyeong Lee; Eunhye Kim; Seon-Ung Hwang; Junchul-David Yoon; Lian Cai; Mirae Kim; Gahye Kim; Hyerin Choi; Sang-Hwan Hyun
Journal:  Animals (Basel)       Date:  2021-03-08       Impact factor: 2.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.